AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 267 filers reported holding AVANOS MED INC in Q3 2021. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $69,000 | -24.2% | 2,507 | -7.3% | 0.00% | -100.0% |
| Q1 2022 | $91,000 | +19.7% | 2,704 | +23.9% | 0.00% | 0.0% |
| Q4 2021 | $76,000 | +28.8% | 2,183 | +15.6% | 0.00% | – |
| Q3 2021 | $59,000 | -21.3% | 1,888 | -8.5% | 0.00% | -100.0% |
| Q2 2021 | $75,000 | -26.5% | 2,064 | -11.5% | 0.00% | 0.0% |
| Q1 2021 | $102,000 | -60.9% | 2,332 | -59.0% | 0.00% | -66.7% |
| Q4 2020 | $261,000 | +39.6% | 5,682 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $187,000 | +3.3% | 5,652 | -6.3% | 0.00% | 0.0% |
| Q2 2020 | $181,000 | -5.7% | 6,034 | +17.6% | 0.00% | -57.1% |
| Q3 2019 | $192,000 | -15.0% | 5,131 | -1.0% | 0.01% | -12.5% |
| Q2 2019 | $226,000 | +310.9% | 5,182 | +305.5% | 0.01% | +300.0% |
| Q1 2019 | $55,000 | 0.0% | 1,278 | +4.2% | 0.00% | -33.3% |
| Q4 2018 | $55,000 | -46.6% | 1,226 | -18.5% | 0.00% | -40.0% |
| Q3 2018 | $103,000 | +267.9% | 1,505 | +211.0% | 0.01% | +150.0% |
| Q2 2018 | $28,000 | – | 484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,310,272 | $63,163,000 | 4.83% |
| RGM Capital, LLC | 2,978,889 | $81,443,000 | 4.25% |
| Tributary Capital Management, LLC | 586,117 | $16,024,000 | 1.59% |
| HEARTLAND ADVISORS INC | 395,141 | $10,803,000 | 0.75% |
| Hillsdale Investment Management Inc. | 169,400 | $4,631,000 | 0.37% |
| WESTWOOD HOLDINGS GROUP INC | 1,068,905 | $29,225,000 | 0.32% |
| Keene & Associates, Inc. | 11,642 | $318,000 | 0.30% |
| Wakefield Asset Management LLLP | 24,356 | $666,000 | 0.28% |
| CORNERCAP INVESTMENT COUNSEL INC | 36,025 | $985,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 26,366 | $721,000 | 0.11% |